QID 239862

Date Published: 2021-11-11

QID 239862: Red Hat Update for annobin (RHSA-2021:4598)

annobin provides a compiler plugin to annotate and tools to examine compiled binary files.

Security Fix(es):
  • developer environment: unicode's bidirectional (bidi) override characters can cause trojan source attacks (cve-2021-42574)

Affected Products:

  • Red Hat enterprise linux for x86_64 - extended update support 8.4 x86_64
  • Red Hat enterprise linux server - aus 8.4 x86_64
  • Red Hat enterprise linux for ibm z systems - extended update support 8.4 s390x
  • Red Hat enterprise linux for power, little endian - extended update support 8.4 ppc64le
  • Red Hat enterprise linux server - tus 8.4 x86_64
  • Red Hat enterprise linux for arm 64 - extended update support 8.4 aarch64
  • Red Hat enterprise linux server (for ibm power le) - update services for sap solutions 8.4 ppc64le
  • Red Hat enterprise linux server - update services for sap solutions 8.4 x86_64



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

On successful exploitation, it could allow an attacker to execute code.

  • CVSS V3 rated as Critical - 8.3 severity.
  • CVSS V2 rated as Medium - 5.1 severity.
    • Solution
    Upgrade to the latest packages which contain a patch.

    Refer to Refer to :
    Applying Package Updates to RHEL system     for details.

    Refer to Red Hat security advisory RHSA-2021:4598 Update to address this issue and obtain more information.

    Vendor References

    CVEs related to QID 239862

    CVE-2021-42574 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2021:4598 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2021:4598
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].